Efficacy and safety of lamotrigine as add-on treatment to lithium in bipolar depression: A multicenter, double-blind, placebo-controlled trial

Journal of Clinical Psychiatry

Volumn 70, Issue 2, 2009, Pages 223-231

  Van Der Loos, Marc L M ^a   Mulder, Paul G H ^b   Hartong, Erwin G Th M ^c   Blom, Marc B J ^d   Vergouwen, Anton C ^e   De Keyzer, Herman J U E M ^f   Notten, Peter J H ^g   Luteijn, Marijke L ^h   Timmermans, Manuela A ⁱ   Vieta, Eduard ^j   Nolen, Willem A ^k  

^a Location Sophia ^*  (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c CANISIUS WILHELMINA HOSPITAL   (Netherlands)

^d PARNASSIA PSYCHIATRIC INSTITUTE   (Netherlands)

^e ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^f Retranchement   (Netherlands)

^g CPRLab   (Netherlands)

^h ALBERT SCHWEITZER HOSPITAL   (Netherlands)

ⁱ GLAXOSMITHKLINE   (Netherlands)

^j UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^k UNIVERSITY OF BARCELONA   (Spain)

more..

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; LITHIUM CARBONATE; ANTICONVULSIVE AGENT; TRANQUILIZER; TRIAZINE DERIVATIVE;

ADD ON THERAPY; ADULT; AGITATION; ALGORITHM; ARTHRALGIA; ARTICLE; BACKACHE; BIPOLAR DEPRESSION; CLINICAL GLOBAL IMPRESSION SCALE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FATIGUE; FEMALE; FLU LIKE SYNDROME; HEADACHE; HUMAN; HYPOMANIA; INSOMNIA; MAJOR CLINICAL STUDY; MALE; MANIA; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MULTICENTER STUDY; MYALGIA; NAUSEA; OUTCOME ASSESSMENT; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RASH; SCORING SYSTEM; SIDE EFFECT; SKIN MANIFESTATION; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TREMOR; BIPOLAR DISORDER; DOSE RESPONSE; DRUG ADMINISTRATION; DRUG COMBINATION; MAJOR DEPRESSION; MIDDLE AGED; PSYCHOLOGICAL ASPECT; PSYCHOLOGICAL RATING SCALE;

ADULT; ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; DEPRESSIVE DISORDER, MAJOR; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; LITHIUM CARBONATE; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TRIAZINES;

EID: 62649121952     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.08m04152     Document Type: Article

References (39)

1. Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry 2003;60:261-269 (Pubitemid 36307437)
2. Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry 2002;59:530-537 (Pubitemid 34602935)
3. Kupka RW, Luckenbaugh DA, Post RM, et al. Comparison of rapidcycling and non-rapid-cycling bipolar disorder based on prospective mood ratings in 539 outpatients. Am J Psychiatry 2005;162:1273-1280 (Pubitemid 40905577)
4. Calabrese JR, Hirschfeld RMA, Frye MA, et al. Impact of depressive symptoms compared with manic symptoms in bipolar disorder: results of a US community-based sample. J Clin Psychiatry 2004;65(11): 1499-1504
5. Ernst CL, Goldberg JF. Antidepressant properties of anticonvulsant drugs for bipolar disorder. J Clin Psychopharmacol 2003;23:182-192 (Pubitemid 36368796)
6. Malhi GS, Mitchell PB, Salim S. Bipolar depression: management options. CNS Drugs 2003;17:9-25 (Pubitemid 36044346)
7. Geddes JR, Burgess S, Hawton K, et al. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry 2004;161:217-222 (Pubitemid 38419270)
8. Tohen M, Vieta E, Calabrese J, et al. Efficacy of olanzapine and olanzapine-fluoxetine combination in the treatment of bipolar I depression. Arch Gen Psychiatry 2003;60:1079-1088 (Pubitemid 37429647)
9. Calabrese JR, Keck PE Jr., Macfadden W, et al. A randomized, double- blind, placebo-controlled trial of quetiapine in the treatment of bipolar I or II depression. Am J Psychiatry 2005 Jul;16(7)2:1351-1360 (Pubitemid 40905587)
10. Gao K, Gajwani P, Elhaj O, et al. Typical and atypical antipsychotics in bipolar depression. J Clin Psychiatry 2005;66(11):1376-1385 (Pubitemid 41779535)
11. Gijsman HJ, Geddes JR, Rendell JM, et al. Antidepressants for bipolar depression: a systematic review of randomized, controlled trials. Am J Psychiatry 2004;161:1537-1547 (Pubitemid 39201448)
12. Sachs GS, Nierenberg AA, Calabrese JR, et al. Effectiveness of adjunctive antidepressant treatment for bipolar depression. N Engl J Med 2007;356:1711-1722 (Pubitemid 46658703)
13. Nemeroff CB, Evans DL, Gyulai L, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry 2001;158:906-912 (Pubitemid 32547620)
14. Altshuler LL, Post RM, Leverich GS, et al. Antidepressant-induced mania and cycle acceleration: a controversy revisited. Am J Psychiatry 1995;152:1130-1138
15. Sporn J, Sachs G. The anticonvulsant lamotrigine in treatment-resistant manic-depressive illness. J Clin Psychopharmacol 1997;17:185-189 (Pubitemid 27261773)
16. Kusumakar V, Yatham LN. An open study of lamotrigine in refractory bipolar depression. Psychiatry Res 1997;72:145-148 (Pubitemid 27425457)
17. Calabrese JR, Fatemi SH, Woyshville MJ. Antidepressant effects of lamotrigine in rapid cycling bipolar disorder. Am J Psychiatry 1996; 153(9):1236 (Pubitemid 26299855)
18. Calabrese JR, Bowden CL, Sachs GS, et al. A double-blind placebo-controlled study of lamotrigine monotherapy in outpatients with bipolar I depression. Lamictal 602 Study Group. J Clin Psychiatry 1999;60(2): 79-88 (Pubitemid 29104383)
19. Goldsmith DR, Wagstaff AJ, Ibbotson T, et al. Lamotrigine: a review of its use in bipolar disorder. Drugs 2003;63:2029-2050 (Pubitemid 37229087)
20. Calabrese JR, Huffman RF, White RL, et al. Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials. Bipolar Disord 2008;10:323-333
21. Geddes J, Huffman RF, Paska W, et al. Lamotrigine for acute treatment of bipolar depression: additional clinical trial data and a retrospective pooled analysis of response rates across all randomized trials conducted by GSK. Bipolar Disord 2007;8(suppl 1):32
22. Brown EB, McElroy SL, Keck PE, Jr., et al. A 7-week, randomized, double-blind trial of olanzapine/fluoxetine combination versus lamotrigine in the treatment of bipolar I depression. J Clin Psychiatry 2006; 67(7):1025-1033 (Pubitemid 44230872)
23. Frye MA, Ketter TA, Kimbrell TA, et al. A placebo-controlled study of lamotrigine and gabapentin monotherapy in refractory mood disorders. J Clin Psychopharmacol 2000;20:607-614
24. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry 2003;64(9):1013-1024 (Pubitemid 37158246)
25. Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry 2003;60:392-400 (Pubitemid 36403000)
26. Sheehan DV, Lecrubier Y, Sheehan KH, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998;59(suppl 20):22-33 (Pubitemid 29001829)
27. Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry 1979;134:382-389 (Pubitemid 9136500)
28. Spearing MK, Post RM, Leverich GS, et al. Modification of the clinical global impressions (CGI) scale for use in bipolar illness (BP): the CGI-BP. Psychiatry Research 1997;73:159-171 (Pubitemid 28088172)
29. Leverich GS, Nolen WA, Rush AJ, et al. The Stanley Foundation Bipolar Treatment Outcome Network. I. Logitudinal methodology. J Affect Disord 2001;67(1-3):33-44
30. Bhagwagar Z, Goodwin GM. The role of lithium in the treatment of bipolar depression. Clin Neurosci Res 2002;2:222-227 (Pubitemid 35375335)
31. Consoni FT, Vital MA, Andreatini R. Dual monoamine modulation for the antidepressant-like effect of lamotrigine in the modified forced swimming test. Eur Neuropsychopharmacol 2006;16:451-458 (Pubitemid 43996884)
32. Corbella B, Vieta E. Molecular targets of lithium action. Acta Neuropsychiatrica 2003;15:1-25 (Pubitemid 37490140)
33. Chen C, Veronese L, Yin Y. The effects of lamotrigine on the pharmacokinetics of lithium. Br J Clin Pharmacol 2000;50:193-195
34. Vieta E, Carne X. The use of placebo in clinical trials on bipolar disorder: a new approach for an old debate. Psychother Psychosom 2005;74:10-16 (Pubitemid 40091413)
35. Vieta E, Calabrese JR, Hennen J, et al. Comparison of rapid-cycling and non-rapid-cycling bipolar I manic patients during treatment with olanzapine: analysis of pooled data. J Clin Psychiatry 2004(10);65:1420-1428
36. Suppes T, Ozcan ME, Carmody T. Response to clozapine of rapid cycling versus non-cycling patients with a history of mania. Bipolar Disord 2004;6:329-332 (Pubitemid 39077095)
37. Post RM, Altshuler LL, Leverich GS, et al. Mood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline. Br J Psychiatry 2006;189:124-131 (Pubitemid 44231270)
38. Vieta E, Martinez-Aran A, Goikolea JM, et al. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers. J Clin Psychiatry 2002;63(6):508-512 (Pubitemid 34680359)
39. Leverich GS, Altshuler LL, Frye MA, et al. Risk of switch in mood polarity to hypomania or mania in patients with bipolar depression during acute and continuation trials of venlafaxine, sertraline, and bupropion as adjuncts to mood stabilizers. Am J Psychiatry 2006;163:232-239 (Pubitemid 44480842)